The latest research from Fore Pharma, Global Benign Prostatic Hyperplasia Market and Competitive Landscape – 2020, provides comprehensive insights into Benign Prostatic Hyperplasia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Benign Prostatic Hyperplasia market size and drug sales. It also provides insights into Benign Prostatic Hyperplasia epidemiology and late stage pipeline.
This research covers the following – Benign Prostatic Hyperplasia treatment options, Benign Prostatic Hyperplasia late stage clinical trials pipeline, Benign Prostatic Hyperplasia prevalence by countries, Benign Prostatic Hyperplasia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Benign Prostatic Hyperplasia pipeline: Find out drugs in clinical trials for Benign Prostatic Hyperplasia by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Benign Prostatic Hyperplasia epidemiology: Find out number of patients diagnosed (prevalence) with Benign Prostatic Hyperplasia by countries
– Benign Prostatic Hyperplasia drugs: Identify key drugs marketed and prescribed for Benign Prostatic Hyperplasia by countries, including trade name, molecule name, and company
– Benign Prostatic Hyperplasia drugs sales: Find out the sales value for Benign Prostatic Hyperplasia drugs by countries
– Benign Prostatic Hyperplasia market valuations: Find out the market size for Benign Prostatic Hyperplasia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Benign Prostatic Hyperplasia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Benign Prostatic Hyperplasia drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Benign Prostatic Hyperplasia market
– Develop in-depth knowledge of competition and markets
– Analyze Benign Prostatic Hyperplasia drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Benign Prostatic Hyperplasia market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Benign Prostatic Hyperplasia Treatment Options
2. Benign Prostatic Hyperplasia Pipeline Insights
2.1. Benign Prostatic Hyperplasia Phase 3 Clinical Trials
2.2. Benign Prostatic Hyperplasia Phase 2 Clinical Trials
2.3. Benign Prostatic Hyperplasia Phase 1 Clinical Trials
3. Benign Prostatic Hyperplasia Epidemiology Analysis by Countries
4. US Benign Prostatic Hyperplasia Market Insights
4.1. Marketed Drugs for Benign Prostatic Hyperplasia in US
4.2. US Benign Prostatic Hyperplasia Market Size & Forecast
4.3. US Benign Prostatic Hyperplasia Drugs Sales & Forecast
4.4. US Benign Prostatic Hyperplasia Market Share Analysis
5. Germany Benign Prostatic Hyperplasia Market Insights
5.1. Marketed Drugs for Benign Prostatic Hyperplasia in Germany
5.2. Germany Benign Prostatic Hyperplasia Market Size & Forecast
5.3. Germany Benign Prostatic Hyperplasia Drugs Sales Forecast
5.4. Germany Benign Prostatic Hyperplasia Market Share Analysis
6. France Benign Prostatic Hyperplasia Market Insights
6.1. Marketed Drugs for Benign Prostatic Hyperplasia in France
6.2. France Benign Prostatic Hyperplasia Market Size & Forecast
6.3. France Benign Prostatic Hyperplasia Product Sales Forecast
6.4. France Benign Prostatic Hyperplasia Market Share Analysis
7. Italy Benign Prostatic Hyperplasia Market Insights
7.1. Marketed Drugs for Benign Prostatic Hyperplasia in Italy
7.2. Italy Benign Prostatic Hyperplasia Market Size & Forecast
7.3. Italy Benign Prostatic Hyperplasia Product Sales Forecast
7.4. Italy Benign Prostatic Hyperplasia Market Share Analysis
8. Spain Benign Prostatic Hyperplasia Market Insights
8.1. Marketed Drugs for Benign Prostatic Hyperplasia in Spain
8.2. Spain Benign Prostatic Hyperplasia Market Size & Forecast
8.3. Spain Benign Prostatic Hyperplasia Product Sales Forecast
8.4. Spain Benign Prostatic Hyperplasia Market Share Analysis
9. UK Benign Prostatic Hyperplasia Market Insights
9.1. Marketed Drugs for Benign Prostatic Hyperplasia in UK
9.2. UK Benign Prostatic Hyperplasia Market Size & Forecast
9.3. UK Benign Prostatic Hyperplasia Product Sales Forecast
9.4. UK Benign Prostatic Hyperplasia Market Share Analysis
10. Europe Benign Prostatic Hyperplasia Market Insights
10.1. Europe Benign Prostatic Hyperplasia Market Size & Forecast
10.2. Europe Benign Prostatic Hyperplasia Product Sales Forecast
10.3. Europe Benign Prostatic Hyperplasia Market Share Analysis
11. Japan Benign Prostatic Hyperplasia Market Insights
11.1. Marketed Drugs for Benign Prostatic Hyperplasia in Japan
11.2. Japan Benign Prostatic Hyperplasia Market Size & Forecast
11.3. Japan Benign Prostatic Hyperplasia Product Sales Forecast
11.4. Japan Benign Prostatic Hyperplasia Market Share Analysis
12. Global Benign Prostatic Hyperplasia Market Insights
12.1. Global Benign Prostatic Hyperplasia Market Size & Forecast
12.2. Global Benign Prostatic Hyperplasia Product Sales Forecast
12.3. Global Benign Prostatic Hyperplasia Market Share Analysis
13. Research Methodology
List of Tables
1: Benign Prostatic Hyperplasia Phase 3 Clinical Trials, Global, 2020
2: Benign Prostatic Hyperplasia Phase 2 Clinical Trials, Global, 2020
3: Benign Prostatic Hyperplasia Phase 1 Clinical Trials, Global, 2020
4: Benign Prostatic Hyperplasia Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Benign Prostatic Hyperplasia in US, 2019
6: US Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
7: US Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
8: US Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Benign Prostatic Hyperplasia in Germany, 2019
10: Germany Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
11: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
12: Germany Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Benign Prostatic Hyperplasia in France, 2019
14: France Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
15: France Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
16: France Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Benign Prostatic Hyperplasia in Italy, 2019
18: Italy Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
19: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
20: Italy Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Benign Prostatic Hyperplasia in Spain, 2019
22: Spain Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
23: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
24: Spain Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Benign Prostatic Hyperplasia in UK, 2019
26: UK Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
27: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
28: UK Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
29: Europe Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
30: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Benign Prostatic Hyperplasia in Japan, 2019
32: Japan Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
33: Japan Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
34: Japan Benign Prostatic Hyperplasia Market Events and Trends, 2016 – 2025
35: Global Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 – 2025
36: Global Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
List of Figures
1: Benign Prostatic Hyperplasia Pipeline by Phase (%), Global, 2020
2: Benign Prostatic Hyperplasia Prevalence by Countries, 2016 – 2025
3: US Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
4: US Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
5: US Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
6: US Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
7: Germany Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
8: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
9: Germany Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
10: Germany Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
11: France Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
12: France Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
13: France Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
14: France Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
15: Italy Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
16: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
17: Italy Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
18: Italy Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
19: Spain Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
20: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
21: Spain Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
22: Spain Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
23: UK Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
24: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
25: UK Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
26: UK Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
27: Europe Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
28: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
29: Europe Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
30: Europe Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
31: Japan Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
32: Japan Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
33: Japan Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
34: Japan Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
35: Global Benign Prostatic Hyperplasia Market Size ($mn), 2016 – 2025
36: Global Benign Prostatic Hyperplasia Product Sales ($mn), 2016 – 2025
37: Global Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
38: Global Benign Prostatic Hyperplasia Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.